Representative Image
Antiviral drug Remdesivir has shown positive results in the treatment of COVID-19 patients, US-based pharma company Gilead Sciences has said.
In its third phase of clinical trial, a 5-day dosage of the medicine has reportedly improved the condition of 50 per cent of the patients with many discharged from hospitals in two weeks.
“Certainly, it’s a positive, a very positive event,” US President Donald Trump told reporters on Wednesday in response to a question related to the development of Remdesivir.
However, the drug has not been licensed or approved globally for the treatment of COVID-19 patients.
Meanwhile, a study to determine the efficacy of the medicine for a five-day course as compared to a 10-day treatment regime is underway, the company said.
Remdesivir was found to kill viruses like Ebola, Marburg, MERS and SARS. The medication disables virus RNA (ribonucleic acid) replication.
However, the drug failed the human trial stage for treating the Ebola virus in 2018-19.
Baripada: A newborn girl was found lying near a bush at Bhanra village under Karanjia…
Mumbai: Salman Khan and Shah Rukh Khan, the leading superstars of Bollywood, came from different…
Mumbai: Actor-filmmaker Dhanush took to his X handle on Friday to announce the release date…
Chennai: Odisha all but booked a berth in the knockout stage of the 14th Hockey…
Cuttack: Several traffic restrictions have been imposed to ensure smooth movement of devotees to Dhabaleswar…
Mumbai: Sidhu Moose Wala's parents Balkaur Singh and Charan Kaur shared a picture of their…
New York: A group of American women has launched an unprecedented protest against men who…
Bhubaneswar: Four more handicrafts were granted approval by the Odisha government, taking the total number…